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Deep osteochondral defects may leave voids in the subchondral bone, increasing the
risk of joint structure collapse. To ensure a stable foundation for the cartilage repair,
bone grafts can be used for filling these defects. Poly(lactide‐co‐glycolide) (PLGA) is a
biodegradable material that improves bone healing and supports bone matrix deposi-
tion. We compared the reparative capacity of two investigative macroporous PLGA‐
based biomaterials with two commercially available bone graft substitutes in the bony
part of an intra‐articular bone defect created in the lapine femur. New Zealand white
rabbits (n = 40) were randomized into five groups. The defects, 4 mm in diameter and
8 mm deep, were filled with neat PLGA; a composite material combining PLGA and
bioactive glass fibres (PLGA–BGf); commercial beta‐tricalcium phosphate (β‐TCP)
granules; or commercial bioactive glass (BG) granules. The fifth group was left
untreated for spontaneous repair. After three months, the repair tissue was evaluated
with X‐ray microtomography and histology. Relative values comparing the operated
knee with its contralateral control were calculated. The relative bone volume fraction
(ΔBV/TV) was largest in the β‐TCP group (p ≤ 0.012), which also showed the most
abundant osteoid. BG resulted in improved bone formation, whereas defects in the
PLGA–BGf group were filled with fibrous tissue. Repair with PLGA did not differ from
spontaneous repair. The PLGA, PLGA–BGf, and spontaneous groups showed thicker
and sparser trabeculae than the commercial controls. We conclude that bone repair
with β‐TCP and BG granules was satisfactory, whereas the investigational PLGA‐
based materials were only as good as or worse than spontaneous repair.
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Joint trauma may lead to deep osteochondral defects with
severe subchondral bone loss (van Dijk, Reilingh, Zengerink, & van
Bergen, 2010). The impairment of joint biomechanics and tissue
metabolism leads to dysfunction of the joint and increases the riskwileyonlinelibrary.com/of posttraumatic osteoarthritis and collapse of the joint structure
(McKinley, Borrelli, D'Lima, Furman, & Giannoudis, 2010). These
can lead to pain, swelling, and restricted movement of the joint
(Jackson, Lalor, Aberman, & Simon, 2001).
Due to the poor intrinsic repair capacity of cartilage and osteoar-
thritis as the potential consequence of cartilage lesions, various© 2019 John Wiley & Sons, Ltd.journal/term 1
2 SALONIUS ET AL.treatment options have been developed to preserve joints after dam-
age (Huey, Hu, & Athanasiou, 2012). The current surgical methods to
treat osteochondral defects include autologous osteochondral trans-
fer, fresh osteochondral allografts, autologous chondrocyte implanta-
tion, and arthroplasty (Seo, Mahapatra, Singh, Knowles, & Kim,
2014). The choice of a treatment option depends on the size, depth,
and location of the lesion as well as the age and previous treatments
of the patient.
In intra‐articular bone fractures and deep osteochondral defects,
both the articular cartilage and the underlying bone should be taken
into consideration when choosing the treatment method (Mano &
Reis, 2007). Large bone voids should be filled with bone grafts to pro-
vide the healing defect site with sufficient structural support, which is
a prerequisite for a successful cartilage repair. Autografts are the gold
standard of bone grafting. Due to the limited availability, donor site
morbidity, pain, and risk of infection and nerve injury (Arrington,
Smith, Chambers, Bucknell, & Davino, 1996), allografts harvested from
a cadaver have been used as an alternative source. However, allografts
are associated with the risk of immune reaction and disease transmis-
sion. Tissue‐engineered substitutes have been developed to overcome
these limitations (Oryan, Alidadi, Moshiri, & Maffulli, 2014).
An advantageous bone filler that could be used together with a
cartilage reparative construct remains to be developed. An optimal
bone filler in a deep osteochondral defect would provide the tissue
with mechanical support, be able to function as a carrier for reparative
cells, degrade gradually as neotissue forms, and enable cartilage repa-
ration (Oryan et al., 2014).
Several biomaterials have been studied for bone applications.
Bioceramics, calcium phosphates, such as osteoconductive beta‐
tricalcium phosphate (β‐TCP), have been used in clinical practice for
over 20 years (Ghazal, Prein, & Müller, 1992; Stahl & Froum, 1986).
β‐TCP resorbs by osteoclastic activity and is replaced by new bone
in vivo (Eggli, Muller, & Schenk, 1988). Friability and a limited osteo-
genic effect are the main problems encountered with β‐TCP (Liu &
Lun, 2012). Bioactive glasses (BGs) are silica‐based materials that pro-
mote bone formation and have been in clinical use since the 1980s
(Brauer, 2015; Keranen et al., 2011). Some BGs have shown antibacte-
rial properties, thus mitigating the risk of surgical infections (Lindfors
et al., 2010). BGs, like β‐TCP, are brittle, and thus their mechanical
properties are limited (Jones, 2013).
Bioabsorbable polymers have been actively studied as bone filler
materials. Aliphatic polyesters of alpha‐hydroxy acids are the most
commonly used, and poly(lactide‐co‐glycolide) (PLGA) is often
favoured in regenerative medicine due to its biocompatibility, rela-
tively rapid and controllable degradation, and existing approval for
clinical use by the U.S. Food and Drug Administration (Gentile, Chiono,
Carmagnola, & Hatton, 2014,Serino, Rao, Iezzi, & Piattelli, 2008).
Three‐dimensional scaffolds made of PLGA have been shown to sup-
port cell attachment and bone matrix deposition on the scaffold sur-
face and to promote bone healing compared with spontaneous
repair (Karp, Shoichet, & Davies, 2003; Kleinschmidt, Marden, Kent,
Quigley, & Hollinger, 1993). The acidic by‐products that form during
the degradation process as well as poor mechanical strength are the
main limitations of synthetic polymers (Garcia‐Gareta, Coathup, &
Blunn, 2015).Results of the use of porous PLGA scaffolds in the repair of bone
defects have been promising (Pan et al., 2015). In our preliminary
study in rats (unpublished), there was an island‐like bone formation
inside the implanted PLGA in the absence of inflammatory cells. Thus,
we hypothesized that a porous plug‐like PLGA rod could meet the
requirements for a bone filler in osteochondral defects. We produced
a cylindrical scaffold by gas foaming (CO2) PLGA to be tested in vivo in
a rabbit model.
Although polymer scaffolds are biocompatible, they lack sufficient
bioactivity (Zeimaran et al., 2015). As BG has shown osteoconductive
properties (Gunn, Rekola, Hirvonen, & Aho, 2013), we hypothesized
that combining PLGA with bioactive glass fibres (BGf) would enhance
the regenerative capacity of the biomaterial. Therefore, we also pro-
duced a rod‐formed composite material combining PLGA with BGf in
a freeze‐drying process.
The purpose of this study was to evaluate the potential of two
investigational PLGA‐based biomaterials against two commercial bio-
materials, and lesions left without treatment, in the repair of the bony
part of deep osteochondral defects in a rabbit model.2 | MATERIALS AND METHODS
A total of 40 female New Zealand white rabbits were obtained
from a commercial supplier (Harlan Laboratories B.V., Venray, the
Netherlands). The animals were 18 weeks old. They were housed in
individual cages, acclimatized for 1 week before the operations, and
their wellbeing was observed daily. The study was authorized by the
Finnish National Animal Experiment Board (ESAVI/3785/04.10.03/
2011) and conducted according to the ethical guidelines and regula-
tions of the Finnish Act on Animal Experimentation (62/2006). The
rabbits were randomized into five groups (n = 8 in each group). Four
groups received PLGA, PLGA–BGf, commercial BG, or commercial
β‐TCP as a bone substitute material (Figure 1a). The fifth group was
an untreated control group (spontaneous), which did not receive any
bone substitute material.2.1 | Preparation of the biomaterials
PLGA polymers were produced at Åbo Akademi University. Medical
grade monomers of D‐lactide and glycolide were acquired from
Corbion (Corbion Purac, Gorinchem, the Netherlands) and L‐lactide
from Futerro (Escanaffles, Spain). The PLGA was polymerized in an
argon atmosphere by ring‐opening polymerization with 0.1mol‐%
stannous octoate as initiator and a molecular weight determining
amount of 1‐decanol as coinitiator. After polymerization, the polymer
was purified by dissolution in dichloromethane and precipitation in
ethanol. The PLGA had a lactide to glycolide ratio of 7:3 with equal
amounts of D‐ and L‐lactide and a weight average molecular weight
of 48 000 g/mol.
PLGA scaffolds were produced at Åbo Akademi University with
the gas foaming method. PLGA was first extruded into approximately
2.8 mm thick rods, which were cut to 16‐mm long pieces. The PLGA
pieces were then placed in custom‐made Teflon molds with an inner
diameter of 4.0 mm. The molds were placed in a chamber with a
FIGURE 1 (a) A photograph of all the
investigated bone substitutes from left to
right: poly(lactide‐co‐glycolide) (PLGA),
poly(lactide‐co‐glycolide)–bioactive glass
fibres (PLGA–BGf), beta‐tricalcium phosphate
(β‐TCP), and bioactive glass (BG). The site of
the defect in the medial condyle of the femur
(b) and its depth into the bone tissue (c) are
indicated with a black line [Colour figure can
be viewed at wileyonlinelibrary.com]
SALONIUS ET AL. 3carbon dioxide pressure of 55 bar for 10 hr, then the pressure was
released rapidly in 5 s. The rods were to some extent soft with a
porosity of over 90%, which consisted of mainly closed pores. Scaf-
folds with the length of 8 mm and a mass of 24–27 mg were then
cut from the foamed rods and sterilized with gamma irradiation with
a dose of 25 kGy.
The PLGA–BGf composites were produced at Tampere Univer-
sity of Technology. Bioresorbable melt‐derived glass fibres (Vivoxid
Ltd., Turku, Finland), denoted as BGf, were composed of 68.6 SiO2,
12.5 Na2O, 9.3 CaO, 7.2 MgO, 1.8 B2O3, and 0.6 P2O5 (in mol‐%).
The average fibre diameter was 13 μm. The BGf was cut into staple
fibres of approximately 10 cm in length and carded into mesh. The
above described PLGA was dissolved in 1,4‐dioxane as 3 wt‐% solu-
tion. The 3 wt‐% PLGA solution was immersed into BGf carded mesh,
and the samples were frozen to −30°C for 24 hr prior to 24‐hr
freeze‐drying. The freeze‐dried PLGA–BGf composites were after-
wards cut with a puncher into samples with diameter of 4 mm, and
five parallel samples were placed on top of each other and glued
together with 3 wt‐% PLGA solution and freeze‐dried again as
described earlier. The height of the final sample was 8 mm, with a
porosity of 96% (Haaparanta et al., 2015). The samples were held
under vacuum at room temperature for a minimum of 48 hr and
gamma sterilized at 25 kGy.
PLGA and PLGA–BGf were compared with two commercial
bone substitutes, BG granules (BonAlive®, BonAlive Biomaterials
Ltd, Turku, Finland) and β‐TCP granules (Synthes® chronOS, Synthes
GmbH, Oberdorf, Switzerland), and with spontaneous repair.
BonAlive® granules are BG granules consisting of 53 SiO2, 23
Na2O, 20 CaO, and 4 P2O5 (in wt‐%). The BG granules had a diam-
eter of 0.5–0.8 mm. Synthes® chronOS granules are composed of
β‐TCP. The sizes of these granules were 0.5–0.7 mm, and the poros-
ity of the material was 60%.2.2 | Surgical procedure
The rabbits were operated under general anaesthesia induced with
0.5 mg/kg (sc) medetomidine and 25 mg/kg (sc) ketamine. Preopera-
tive analgesia of 0.05 mg/kg (sc) of buprenorphine and 4 mg/kg (sc)
of carprofen was administered. All the animals received 40 mg/kg
(im) of cefuroxime preoperatively.
The animals were set on a supine position on the operating table.
A medial parapatellar arthrotomy was made to the right hind leg. The
patella was dislocated laterally, and the femoral condyles were
exposed. A single lesion through the articular cartilage of the medial
condyle was made with a hand‐operated drill. The lesion covered
almost the width of the femoral condyle, and the bony defect com-
prised a notable volume of the entire condyle with a diameter of
4 mm and a depth of 8 mm (as depicted in Figure 1b,c). The defect
extended into the bone marrow space. The lesions were filled with
the studied biomaterial or left empty for spontaneous repair. The
granular materials BG and β‐TCP were mixed with sterile water to cre-
ate a paste‐like composition prior to implantation. The PLGA and
PLGA–BGf samples were semirigid plugs, which were press‐fitted into
the lesion (Figure 1a). The incisions were closed in layers. After the
operation, 1 mg/kg (sc) of antipamexole was administered for reversal
of the sedative effects of medetomidine.
The animals were allowed free weight‐bearing and unrestricted
movement after the operation. Antibiotic prophylaxis of 40 mg/kg
(sc) of cefuroxime was continued three times a day for 3 days and
postoperative analgesia of 0.01 mg/kg (sc) of buprenorphine and
4 mg/kg (sc) of carprofen for 4 days.
The follow‐up time for each group was 12 weeks, whereafter the
animals were anaesthetized as described above and euthanized with
an overdose of pentobarbital (60 mg/kg, iv). The operated and
nonoperated contralateral knees were photographed, evaluated for
4 SALONIUS ET AL.gross macroscopic appearance, detached, and stored in 10% buffered
formalin at +4°C for further processing.2.3 | X‐ray microtomography
Quantitative analyses of the operated femoral condyles were carried
out with X‐ray microtomography (μCT) imaging. Bone growth into
the lesion and the subchondral bone morphology of the operated
and nonoperated contralateral knees were analysed with Zeiss Xradia
MicroXCT‐400 (Zeiss, Pleasanton, CA, USA). The samples were trans-
ferred to the temperature of the μCT device (+29°C) for 30 min before
the imaging to stabilize the set‐up. The μCT imaging parameters were
100 kV source voltage (no filtering), 100 μA current, 0.4× macro
objective, 2 binning, 800 projections, 360° projection angle, and
2.5 s exposure time. The cross‐sectional image stacks were recon-
structed using Zeiss Xradia XMReconstructor software (version 8.1,
Zeiss), resulting in a 22.6‐μm isotropic voxel size. The images were
postprocessed and visualized using Avizo Fire 8.1 (FEI Visualization
Sciences Group, Hillsboro, OR, USA) software. A cylindrical volume
of interest (VOI) with a diameter of 5 mm and a depth of 8 mm was
extracted. Subsequently, the VOI was denoised with the non‐local
means (NLM) filter (Buades, Coll, & Morel, 2005). The bone tissue
and the implanted biomaterials were segmented by global
thresholding. Manual correction was used to reduce segmentation
over/under flow.
Quantitative analysis was performed using BoneJ plug‐in (Doube
et al., 2010) in Fiji (Schindelin et al., 2012) software. The analysed
parameters were bone volume fraction (BV/TV), trabecular thickness
(Tb.Th), trabecular spacing (Tb.Sp), and trabecular number (Tb.N).2.4 | Histological analysis
The femurs were carefully split into two using a jig saw. Undecalcified
samples were dehydrated in ethanol, cleared with xylene immersions,
and subsequently embedded in methyl methacrylate. The hardened
tissue blocks were cut into 5‐ to 10‐μm thick sections with a Leica
SM 2500 hard tissue slide microtome. The sections were stained with
Masson–Goldner trichrome stain and mounted with permanent
mounting medium. The sections were imaged with a Zeiss AxioImager
Z1 microscope system equipped with an AxioCam MRc5 camera and
Zen blue edition software (Carl Zeiss Microscopy GmbH, Göttingen,
Germany) to acquire mosaic images of the entire histological sections.
For histomorphometry, the Masson–Goldner trichrome stained
sections were imaged with an Olympus BX‐60 microscope with an
integrated Scion colour digital camera. ImageJ software was used for
measurements, and scaling was performed with UKAS calibrated aux-
iliary object glass with a 1‐mm scale. Semi‐automatic image analysis
with ImageJ was used for measuring the total surface area and the tra-
becular area of the defect. The qualitative assessment of the amount
of osteoid and lymphocytes was carried out with the naked eye.
Due to the low quantity of osteoid in the samples, quantitative assess-
ment of the amount of osteoid could not be made.2.5 | Statistical analyses
Relative μCT values, where each parameter for operated knees was
compared with the corresponding nonoperated controls, were calcu-
lated and used to compare the groups with each other. Statistical anal-
yses were carried out using the permutation analysis of variance test
with Holm adjustment. The p‐values under 0.05 were considered sta-
tistically significant.3 | RESULTS
3.1 | Animal experiment
Three animals (one each from groups PLGA, β‐TCP, and spontaneous)
died during the induction of anaesthesia, probably due to respiratory
arrest caused by the combination of ketamine and medetomidine
(Calasans‐Maia, Monteiro, Ascoli, & Granjeiro, 2009). Consequently,
these three animals were not included in the analyses. Otherwise,
the operations were carried out without complications, and all the ani-
mals recovered well.
3.2 | Macroscopic appearance
There were no signs of synovitis in the operated joints. All groups
showed macroscopic lesion filling up to the joint surface (Figure 2).
Repair tissue hypertrophy over the level of the surrounding cartilage
was detected in two of eight samples in PLGA–BGf group, in one of
six samples in PLGA group, and in one of eight samples in BG group.
No overgrowth was detected in the spontaneously healed or in β‐
TCP‐augmented groups. The surface of the neotissue in the defect
areas in each group was uneven and differed by colour from healthy
cartilage, but no deep tissue deficiencies were detected in the adja-
cent cartilage.
3.3 | Bone repair
Unresolved β‐TCP and BG were still seen in μCT imaging. The bone
and biomaterial could both be distinguished from the μCT images in
all the test groups. The relative bone volume fraction between the
operated and nonoperated knees (ΔBV/TV) was greatly increased in
the β‐TCP group, where it was higher than in the other groups
(p ≤ 0.012, Figure 3a, Table 1, Table S1). The relative trabecular thick-
ness (ΔTb.Th) was higher in groups PLGA, PLGA–BGf, and spontane-
ous than in the commercial controls β‐TCP and BG (p ≤ 0.035;
Figure 3b). All groups differed from each other (p ≤ 0.048) in relative
trabecular spacing (ΔTb.Sp) with the exception of PLGA and spontane-
ous groups, which did not show a statistical difference from one
another (Figure 3c). The trabeculae were sparsest in the PLGA–BGf
group (p ≤ 0.014).
The trabecular number (Tb.N) was close to the contralateral con-
trol in the β‐TCP and BG groups (Figure 3d). These commercial groups
did not differ from one another, but compared with the other groups,
their relative trabecular number (ΔTb.N) was significantly higher
(p ≤ 0.013).
FIGURE 2 Photographs of two representative samples in each
group, showing the macroscopic appearance of the cartilage surface
where the drill hole was created. The groups are as follows: (a,b)
poly(lactide‐co‐glycolide) (PLGA), (c,d) poly(lactide‐co‐glycolide)–
bioactive glass fibres (PLGA–BGf), (e,f) beta‐tricalcium phosphate (β‐
TCP), (g,h) bioactive glass (BG), (i,j) spontaneous, and (k) a nonoperated
contralateral control. Scale bars: 2 mm (a–j) and 5 mm (k) [Colour
figure can be viewed at wileyonlinelibrary.com]
SALONIUS ET AL. 5Table 1 summarizes the results of the μCT imaging in each group
in both the operated knees and the nonoperated contralateral control
knees of the same animals. All statistically significant differences in
ΔBV/TV, ΔTb.Th, ΔTb.Sp, and ΔTb.N are presented in Table S1.3.4 | Repair tissue structure
The filling of the bony lesions seemed to migrate from the edges
towards the middle of the defect. Histological assessment of the sam-
ples showed that the areas that appear empty in μCT images consist
of connective tissue and bone marrow (Figure 4a,b).
In the PLGA and spontaneous groups, the defects were filled
partly with fibrous tissue and partly with mineralized bone surrounded
by scarce strands of osteoid (Figure 4a,b). The upper halves of the
defects were well repaired, but the bone structure in the lower halves
was sparse.
In the PLGA–BGf group, the bone defects were filled with fibrous
tissue (Figure 4a,b). The perimeter of the defect site featured newly
mineralized bone, but the surgically created defect itself showed no
bone tissue formation.
Osteoid was seen in most of the samples, where it was located
directly beneath the surface. Only one specimen in the spontaneously
healed group and one in the PLGA–BGf group had no osteoid
(Table 2). Osteoid was most abundant in the β‐TCP group, where it
encircled numerous small islands of mineralized bone (Figure 4d). Both
commercial controls showed comprehensive lesion filling with tissue
where mineralized bone and osteoid alternated with cell‐rich fibrous
tissue. Although the bone defect filling was satisfactory, there was a
connective tissue‐filled depression near the surface in β‐TCP and BG
groups (Figure 4a,b).
There was a low number of lymphocytes and macrophages in the
histological sections (Table 2). Most inflammatory cells were seen in
the PLGA group, where three of seven specimens showed 50–100
inflammatory cells on the slide, and in the PLGA–BGf group,
where two of eight specimens showed 50–100 inflammatory cells.
No other group showed an increase in the number of lymphocytes
or macrophages.4 | DISCUSSION
In this study, the use of bone defect fillers in intra‐articular lesions was
evaluated in a rabbit model. Our goal was to find out whether these
fillers can be used in repairing the bony part of deep osteochondral
defects. As PLGA‐based scaffolds have been reported to produce
favourable results when used to repair bone defects (Pan et al.,
2015; Penk et al., 2013), we hypothesized that creating a rod‐like
PLGA‐based bone filler would enhance the repair of the deep bony
part of osteochondral defects and that combining BG with PLGA
would further improve the scaffold.
We thought that the PLGA‐based semi‐rigid bone substitutes
might have had additional advantage, as they could be constructed
into a two‐layer scaffold shaped to match the contours of the joint,
with bone substituting material in the deeper part and regenerative
cells for cartilage repair in the joint surface. This kind of a scaffold
could be used as a bioprosthesis to fill the entire osteochondral defect.
Although the gas‐foamed PLGA showed high porosity, the pores
were collapsed (Uppstu, Paakki, & Rosling, 2015). As high porosity is
needed for bone growth into the scaffold (Zeimaran et al., 2015), this
might provide an explanation for the results that were worse than
FIGURE 3 Quantitative results of X‐ray
microtomography showing the difference
between the operated and the nonoperated
contralateral knees in (a) bone volume fraction
(ΔBV/TV, %), (b) trabecular thickness (ΔTb.Th,
μm), (c) trabecular spacing (ΔTb.Sp, μm), (d)
and trabecular number (ΔTb.N, μm−1) in each
study group. The black square represents the
average value of the operated knees, and the
dash line represents the nonoperated knees.
The whiskers represent 95% confidence
intervals
6 SALONIUS ET AL.expected. However, the use of gas‐foamed PLGA produced repair tis-
sue that did not differ from spontaneous healing, indicating that
although it did not have a major overall impact on the healing process,
the repair was not hampered by the material.
BG alone has been shown to work well in bone repair (Lindfors,
Heikkila, Koski, Mattila, & Aho, 2009) and to promote bone formation
in combination with polymers in vitro (Lu, El‐Amin, Scott, & Laurencin,
2003). In the present study, BG alone resulted in adequate bone for-
mation, but combining PLGA with BGf deteriorated the repair process.
PLGA–BGf had initially small pores and compact structure with verylittle space for tissue ingrowth (Haaparanta et al., 2015). The BGfs
were densely embedded in the PLGA, which probably impaired the
interaction of BGf with the surrounding bone. As the composite mate-
rial has a longer degradation time than the PLGA alone, it might lead to
better structural support in load‐bearing applications (Gentile et al.,
2014) but delay the lesion repair (Haaparanta et al., 2015). We believe
these factors explain why the bone defects treated with the PLGA–
BGf composite scaffold were only filled with connective tissue and
why the bone structure remained nearly unchanged throughout the
3‐month long study period.
TABLE 1 Results of the X‐ray microtomography imaging in each group in both the operated knees and the nonoperated contralateral control
knees of the same animals
PLGA PLGA–BGf β‐TCP BG Spontaneous
Mean ± SE Mean ± SE Mean ± SE Mean ± SE Mean ± SE
Operated n = 7 n = 8 n = 7 n = 8 n = 7
BV/TV, % 33.6 ± 1.4 25.1 ± 3.6 46.0 ± 1.3 30.5 ± 1.7 37.1 ± 1.6
Tb.Th (μm) 354 ± 19 295 ± 18 225 ± 10 161 ± 9 364 ± 30
Tb.Sp (μm) 1050 ± 121 1984 ± 178 529 ± 26 632 ± 49 1144 ± 96
Tb.N (μm−1) 0.74 ± 0.05 0.46 ± 0.04 1.33 ± 0.04 1.30 ± 0.08 0.68 ± 0.05
PLGA PLGA–BGf β‐TCP BG Spontaneous
Mean ± SE Mean ± SE Mean ± SE Mean ± SE Mean ± SE
Nonoperated n = 7 n = 8 n = 7 n = 8 n = 7
BV/TV (%) 36.6 ± 0.8 32.6 ± 0.9 31.9 ± 1.5 32.6 ± 1.3 34.4 ± 2.0
Tb.Th (μm) 280 ± 10 228 ± 9 246 ± 12 226 ± 8 277 ± 19
Tb.Sp (μm) 589 ± 22 597 ± 27 695 ± 45 587 ± 19 595.0 ± 36.0
Tb.N (μm−1) 1.16 ± 0.04 1.22 ± 0.05 1.08 ± 0.05 1.24 ± 0.03 1.16 ± 0.05
Note. β‐TCP: beta‐tricalcium phosphate; BG: bioactive glass; BV/TV: bone volume fraction of the total tissue volume; PLGA: poly(lactide‐co‐glycolide);
PLGA–BGf: poly(lactide‐co‐glycolide)–bioactive glass fibres; Tb.N, trabecular number; Tb.Sp, trabecular spacing; Tb.Th, trabecular thickness. The values
are presented as mean ± standard error (SE).
FIGURE 4 An X‐ray microtomography (μCT) image and a Masson–Goldner trichrome‐stained histological section of (a) the best and (b) the worst
sample in each group, chosen according to the data obtained from the μCT imaging, as well as a nonoperated contralateral control (c). The close‐up
image of the best beta‐tricalcium phosphate (β‐TCP) section (d) shows the abundance of osteoid (arrow) in the perimeter of the mineralized bone
(arrowhead). Scale bars: (a–c): 4 mm, (d) 500 μm [Colour figure can be viewed at wileyonlinelibrary.com]
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TABLE 2 Number of animals (n) in each study group that presented with abundant, moderate, little, or no osteoid or 0–50, 50–100, and over
500 inflammatory cells in qualitative assessment of histology. None of the samples were classified to have abundant amounts of osteoid. Most
inflammatory cells were seen in the PLGA and PLGA–BGf groups
Osteoid (n) Inflammatory cells (n)
Abundant Moderate Little No osteoid 0–50 50–100 >500
Group PLGA (n = 7) 0 2 5 0 4 3 0
PLGA–BGf (n = 8) 0 0 7 1 6 2 0
β–TCP (n = 7) 0 3 4 0 7 0 0
BG (n = 8) 0 1 7 0 7 0 0
spontaneous (n = 7) 0 1 5 1 7 0 0
Note. β‐TCP: beta‐tricalcium phosphate; BG: bioactive glass; PLGA: poly(lactide‐co‐glycolide); PLGA–BGf: poly(lactide‐co‐glycolide)–bioactive glass fibres.
The values are presented as mean ± standard error (SE).
8 SALONIUS ET AL.Degradation of PLGA occurs through hydrolysis, which produces
lactic acid and glycolic acid, possibly lowering the pH of its surround-
ings (Gentile et al., 2014; Haaparanta et al., 2015). The inflammatory
reaction and autocatalytic process caused by the acidic environment
have been reported to promote bone reparative process (Mountziaris
& Mikos, 2008; Zeimaran et al., 2015), although contradicting results
have also been presented (Han et al., 2009,Shibutani & Heersche,
1993). In the present study, a slight increase in inflammatory cells
was seen in the PLGA and PLGA–BGf‐treated specimens but not in
the spontaneously healed group or in the groups treated with the
granular biomaterials. However, the minor inflammatory reaction
seen in the PLGA‐based treatment groups did not lead to enhanced
bone repair.
In this study, the β‐TCP group showed most osteoid, numerous
thin trabeculae, and extensive bone formation at 12 weeks. In a previ-
ous study in sheep (Mayr et al., 2015), β‐TCP resorption and bone for-
mation continued for a long time, with only 12% of the biomaterial
being resorbed after 24 weeks. In the present study in rabbits, the
12‐week follow‐up period shows bone repair in its early phase. It is
probable that with time, the bone would have been exposed to
remodelling to normalize the trabecular structure.
The bone volume fraction in the operated knees was close to
that of the nonoperated controls in the spontaneously healed group.
However, the trabeculae were thick and sparse in the spontaneously
healed knees, unlike in the groups treated with the commercial
granular bone substitutes β‐TCP and BG, thus demonstrating a worse
healing response than with the granular bone fillers. BG alone
showed bone trabecular parameters that were closest to those of
the nonoperated contralateral legs, indicating desirable overall repair
tissue quality.
The β‐TCP granules used in this study have been in clinical use in
bone defect repair for over 20 years (Altermatt, Schwobel, & Pochon,
1992). The clinical use of granular β‐TCP and BG in osteochondral
defect filling, however, has been scanty (Hupa & Hupa, 2010).
Granular structure enables easy and complete filling of misshapen
osteochondral lesions, without a need to surgically enlarge the lesion
to fit the shape of the scaffold. Granular bone fillers allow cell migra-
tion into the entire defect site, tissue ingrowth, vascularization, and
well‐functioning metabolism (Virolainen, Heikkila, Yli‐Urpo, Vuorio, &
Aro, 1997; Zerbo, Bronckers, de Lange, & Burger, 2005). In this study,
the commercial materials BG and β‐TCP showed satisfactory lesion fill-
ing and extensive bone formation, indicating that they have potentialto be used in deep osteochondral defect repair. The potential down-
side of granular materials is that the granules might loosen from the
surface. However, in this study, the articulating tibial surface showed
no signs of abrasion by the granules. Adding a cartilage reparative scaf-
fold on top of the bone repair would further secure the granules in
place while restoring the cartilage surface.
There is emerging evidence of crosstalk between articular carti-
lage and underlying subchondral bone that emphasizes the importance
of restoring the joint as a unit (Findlay & Kuliwaba, 2016). Survival of a
whole tissue graft in osteochondral grafting depends largely on the
integration of the graft bone into the host bone (Gross et al., 2008).
Despite the favourable bone repair with the commercial bone
substitute materials, the cartilage unit of the defect, which was left
untreated, was inadequately repaired in the present study. Even
though Masson–Goldner trichrome is not a cartilage staining method,
it gives a general view of the tissue repair. For the tissue section
analysed in the present study for detailed bone formation, it was evi-
dent that there was no or very minor cartilage formation over the
bone regrowth. Thus, none of the studied materials alone were suffi-
cient for the restoration of the entire osteochondral unit. Similar
results were obtained in a study where PLGA was combined with
hydroxyapatite‐β‐TCP (Fan et al., 2013) and in the work of Matsuo
and colleagues (Matsuo et al., 2015) in which osteochondral repair
was studied in a minipig model. A separate cartilage repair procedure
on top of bone repair is therefore needed to restore the chondral part
of the lesion.
The strength of this study is in its comparison of four different
bone fillers with each other and with spontaneous repair. The bone
defects were very large, creating a challenge both for the spontaneous
repair and for the treatment groups. This study was limited by the lack
of a healthy age‐adjusted control group with no surgical procedures. In
this study, it is possible that the operated limb carried less weight
than the contralateral control limb. However, this animal‐specific con-
trol was the same for every group, enabling comparison between the
study groups.5 | CONCLUSIONS
Filling of the bony part of a deep osteochondral lesion with a biode-
gradable gas‐foamed PLGA scaffold resulted in insufficient repair.
Combining PLGA with bioactive glass worsened the repair result.
SALONIUS ET AL. 9The commercial controls with β‐TCP and BG resulted in satisfactory
bone defect filling with more abundant osteoid and mineralized bone
tissue. Thus, these two bone substitute materials have the potential
to be used in deep osteochondral defect repair, given that the carti-
lage unit of the defect is repaired with adequate techniques.
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